The Long-Term Cost-Effectiveness of Twice-Daily Exenatide with Insulin Glargine Versus Once-Daily Liraglutide with Insuline Detemir in Adult Patients with Type 2 Diabetes in Russia
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2092
https://www.valueinhealthjournal.com/article/S1098-3015(15)04168-6/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1507
First Page :
A606
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04168-6&doi=10.1016/j.jval.2015.09.2092